Modified tie-2 receptor ligands
CA 2595037 A1 · Owner: Yancopoulos, George D. · Inventors: Yancopoulos, George D.; Davis, Samuel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides for a modified TIE-2 ligand which has been altered by addition, deletion or substitution of one or more amino acids or , by way of , tagging, with for example the Fc portion of human IgG-1, but which retains its ability ,to bind the TIE-2 receptor. The invention further provides for a modified TIE- 2 ligand , which is a chimeric TIE-2 ligand comprising at least a portion of a first TIE- 2 ligand , and a portion of a second TIE-2 ligand which is different from the first. In a specific , embodiment, the invention further provides for a chimeric TIE ligand comprising at , least a portion of TIE-2 ligand-1 and a portion of TIE-2 ligand-2. In addition the , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 1, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 1, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 1, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.